These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 23211429)

  • 1. Effects upon in-vivo nicotine metabolism reveal functional variation in FMO3 associated with cigarette consumption.
    Bloom AJ; Murphy SE; Martinez M; von Weymarn LB; Bierut LJ; Goate A
    Pharmacogenet Genomics; 2013 Feb; 23(2):62-8. PubMed ID: 23211429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nicotine dependence is associated with functional variation in FMO3, an enzyme that metabolizes nicotine in the brain.
    Teitelbaum AM; Murphy SE; Akk G; Baker TB; Germann A; von Weymarn LB; Bierut LJ; Goate A; Kharasch ED; Bloom AJ
    Pharmacogenomics J; 2018 Jan; 18(1):136-143. PubMed ID: 28290528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotine-
    Perez-Paramo YX; Chen G; Ashmore JH; Watson CJW; Nasrin S; Adams-Haduch J; Wang R; Gao YT; Koh WP; Yuan JM; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2019 Feb; 28(2):311-320. PubMed ID: 30381441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
    Bloom J; Hinrichs AL; Wang JC; von Weymarn LB; Kharasch ED; Bierut LJ; Goate A; Murphy SE
    Pharmacogenet Genomics; 2011 Jul; 21(7):403-16. PubMed ID: 21597399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population distribution of human flavin-containing monooxygenase form 3: gene polymorphisms.
    Cashman JR; Zhang J; Leushner J; Braun A
    Drug Metab Dispos; 2001 Dec; 29(12):1629-37. PubMed ID: 11717182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual differences of human flavin-containing monooxygenase 3: genetic polymorphisms and functional variation.
    Cashman JR; Zhang J
    Drug Metab Dispos; 2002 Oct; 30(10):1043-52. PubMed ID: 12228178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human flavin-containing monooxygenase (form 3): polymorphisms and variations in chemical metabolism.
    Cashman JR
    Pharmacogenomics; 2002 May; 3(3):325-39. PubMed ID: 12052141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in P450 oxidoreductase (POR) A503V and flavin-containing monooxygenase (FMO)-3 E158K is associated with minor alterations in nicotine metabolism, but does not alter cigarette consumption.
    Chenoweth MJ; Zhu AZ; Sanderson Cox L; Ahluwalia JS; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2014 Mar; 24(3):172-6. PubMed ID: 24448396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted sequencing identifies genetic polymorphisms of flavin-containing monooxygenase genes contributing to susceptibility of nicotine dependence in European American and African American.
    Zhang TX; Saccone NL; Bierut LJ; Rice JP
    Brain Behav; 2017 Apr; 7(4):e00651. PubMed ID: 28413702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation.
    Nakajima M; Yokoi T
    Drug Metab Pharmacokinet; 2005 Aug; 20(4):227-35. PubMed ID: 16141602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disposition kinetics and metabolism of nicotine and cotinine in African American smokers: impact of CYP2A6 genetic variation and enzymatic activity.
    Benowitz NL; St Helen G; Dempsey DA; Jacob P; Tyndale RF
    Pharmacogenet Genomics; 2016 Jul; 26(7):340-50. PubMed ID: 27035242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population-specific polymorphisms of the human FMO3 gene: significance for detoxication.
    Cashman JR; Akerman BR; Forrest SM; Treacy EP
    Drug Metab Dispos; 2000 Feb; 28(2):169-73. PubMed ID: 10640514
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism.
    Ring HZ; Valdes AM; Nishita DM; Prasad S; Jacob P; Tyndale RF; Swan GE; Benowitz NL
    Pharmacogenet Genomics; 2007 Dec; 17(12):1007-15. PubMed ID: 18004205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of UGT2B10, UGT2B17, FMO3, and OCT2 genetic variation on nicotine and cotinine pharmacokinetics and smoking in African Americans.
    Taghavi T; St Helen G; Benowitz NL; Tyndale RF
    Pharmacogenet Genomics; 2017 Apr; 27(4):143-154. PubMed ID: 28178031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavin-containing monooxygenase 3 (FMO3): genetic variants and their consequences for drug metabolism and disease.
    Phillips IR; Shephard EA
    Xenobiotica; 2020 Jan; 50(1):19-33. PubMed ID: 31317802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between interindividual differences in nicotine metabolism and CYP2A6 genetic polymorphism in humans.
    Nakajima M; Kwon JT; Tanaka N; Zenta T; Yamamoto Y; Yamamoto H; Yamazaki H; Yamamoto T; Kuroiwa Y; Yokoi T
    Clin Pharmacol Ther; 2001 Jan; 69(1):72-8. PubMed ID: 11180041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation, polymorphism and perspectives for the future of human flavin-containing monooxygenase 3.
    Zhou J; Shephard EA
    Mutat Res; 2006 Jun; 612(3):165-171. PubMed ID: 16481213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic and Nongenetic Factors Associated with Protein Abundance of Flavin-Containing Monooxygenase 3 in Human Liver.
    Xu M; Bhatt DK; Yeung CK; Claw KG; Chaudhry AS; Gaedigk A; Pearce RE; Broeckel U; Gaedigk R; Nickerson DA; Schuetz E; Rettie AE; Leeder JS; Thummel KE; Prasad B
    J Pharmacol Exp Ther; 2017 Nov; 363(2):265-274. PubMed ID: 28819071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP2A6 genotype and the metabolism and disposition kinetics of nicotine.
    Benowitz NL; Swan GE; Jacob P; Lessov-Schlaggar CN; Tyndale RF
    Clin Pharmacol Ther; 2006 Nov; 80(5):457-67. PubMed ID: 17112802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Genetic Variants in the Nicotine Metabolism Pathway on Nicotine Metabolite Levels in Smokers.
    Perez-Paramo YX; Watson CJW; Chen G; Thomas CE; Adams-Haduch J; Wang R; Khor CC; Koh WP; Nelson HH; Yuan JM; Lazarus P
    Cancer Epidemiol Biomarkers Prev; 2023 Jan; 32(1):54-65. PubMed ID: 36252563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.